Cytovation As
Clinical trials sponsored by Cytovation As, explained in plain language.
-
New cancer drug injected directly into tumors shows promise in early trial
Disease control CompletedThis early-stage study tested a new drug, CyPep-1, which is injected directly into tumors. It was combined with the immunotherapy drug pembrolizumab to see if it could help control advanced head and neck cancer, melanoma, or triple-negative breast cancer. The main goals were to c…
Phase: PHASE1, PHASE2 • Sponsor: Cytovation AS • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New 'Tumor-Busting' peptide tested in advanced cancer patients
Disease control CompletedThis early-stage trial tested a new experimental drug called CyPep-1, which is injected directly into tumors. The main goals were to see if it was safe and to find the right dose, both by itself and when combined with an existing immunotherapy drug (pembrolizumab). The study invo…
Phase: PHASE1, PHASE2 • Sponsor: Cytovation AS • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC